Testing one embryo transfer after mosaic PGT results
Part of Women’s health & pregnancy clinical trials.
This study follows people who have infertility and, after IVF testing (PGT), have a “mosaic” embryo result. It looks at transferring one embryo to see how this approach works when mosaic changes are present.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old and are receiving IVF for infertility.
- You completed an IVF cycle with PGT at the Colorado Center for Reproductive Medicine (CCRM) and were told you have a mosaic embryo.
- You agree to transfer only one embryo (not two or more).
- Your case meets the clinic’s medical standards for being able to do an embryo transfer.
- Your mosaic PGT result must not include chromosome errors 13, 18, or 21.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
This study looks at embryo health using a DNA test called PGT-A for couples having IVF. It may help researchers better understand what the test can and cannot tell about which embryos are healthiest.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This trial follows up with people who chose to participate in research when getting preimplantation genetic testing (testing genes in embryos). It may help researchers understand outcomes and improve future genetic testing and counseling.
This trial tests whether using a special time-lapse camera to watch embryos develop, together with genetic testing (PGT), can help choose the healthiest embryos for IVF. It may help improve the chances of a successful pregnancy.
This study looks at whether testing the immune cells in the uterus and then personalizing treatment improves the chance of success for patients who have a single embryo transfer. Eligible patients had the immune test and then a single blastocyst transfer within nine months.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.